期刊名称：HUMAN & EXPERIMENTAL TOXICOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Human and Experimental Toxicology comprehensively covers all aspects of experimental and clinical studies of functional, biochemical and structural disorder.
Articles focus on causes, antidotes and other therapies using:
· Animal and human tissue
· In vitro systems
· Medical and veterinary patients
Publishing preclinical and clinical pharmacology and toxicology original research and reviews, Human and Experimental Toxicology is affiliated to the French Society of
Toxicology.
Who should subscribe to this journal?
Toxicologists
Biochemists
Pharmacologists
Physicians
Veterinarians
Pathologists
Immunologists
Control regulators
Risk managers
Abstracting/Indexing Services:
Academic Search Premier
Biological Abstracts
BIOSIS database
Chemical Abstracts Service (CAS)
Current Citations
Current Contents/ Life Sciences
Elsevier BIOBASE/Current Awareness in Biological Sciences
EMBASE/Excerpta Medica
Index Medicus & MEDLINE
Index Veterinarius
ISI Discovery Agent
Medical Documentation Service
Medline
Neurosciences Abstracts
Nutrition Abstracts & Review Series A: Human & Experimental
Pollution Abstracts
Science Citation Index
Science Citation Index Expanded
Scopus
Instructions to Authors
Human and Experimental Toxicology is an international journal which covers all types of chemical harm to living systems. Papers are published on all aspects of experimental and clinical studies of functional, biochemical, immunological and pathological toxic processes and disorders in vivo and in vitro, on their causal mechanisms, and on toxicity in human and animal patients and on its treatment.
Original research papers, short communications and letters are welcomed. Editorials are invited but they should first be discussed with an editor. Announcements of meetings are published.
Review articles
The editors invite review articles on relevant and current topics in toxicology. Each review should contain a summary, an introduction to the topic, a careful review of the relevant literature, conclusions of the reviewed literature and recommendations, if applicable. The journal will publish both minireviews (about 10 typewritten, double-spaced pages) and full-length, more thorough reviews (not to exceed 50 typewritten, double-spaced pages). The reviews, either minireviews or full-length reviews, should provide a timely view on the topic covered. Figures, figure legends, tables and references are included within the allotted pages.
These reviews should follow the reference, figure, figure legend and table system used for original articles published in Human and Experimental Toxicology.
All papers reporting results of investigations in patients and healthy volunteers must indicate that informed consent was properly obtained and that the work was approved by the relevant Research Ethics Committee (IRB).
Reports of experiments involving animals must indicate that national legislation or the equivalent local standard for protecting animal welfare has been followed.
The Editor may alter manuscripts to make them conform to the stylistic and bibliographic conventions of the journal.
Submission of manuscripts
The Journal of Human & Experimental Toxicology is hosted on ScholarOne™ Manuscripts, a web based online submission and peer review system - SAGE track. Please read the Manuscript Submission guidelines below, and then simply visit http://mc.manuscriptcentral.com/het to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is possible that you will have had an account created.
All papers must be submitted via the online system. If you would like to discuss your paper prior to submission, please refer to the contact details below.
Presentation
Manuscripts should be typed, double-spaced, on one side of the paper only, and should be structured into sections as follows: Title page; Summary and keywords; Introduction; Methods; Results; Discussion; Acknowledgements (details of supporting grants, permission for reproduction of copyright materials, etc.); References.
Each section should begin on a new sheet. Other subsection headings within these main sections may be used but should be limited. The main title should be explicit and specific (80 character limit) and an abbreviated (running) title (40-50 character limit) should be given. The summary should form a synopsis of the work, at the same time underlining the contribution of the research to the understanding of toxicology; it should be less than 200 words in length. Keywords (3-6) must be supplied otherwise the paper cannot be included in the annual index.
Style
For style information and lists of standard abbreviations, consult the American Medical Association Manual of Style: A Guide for Authors and Editors, 9th Edition (Baltimore: Williams & Wilkins,1998). Use metric units throughout the manuscript. The use of footnotes is not permitted. Single quotation marks should be used throughout. Words to be italicised should be underlined. Whenever possible drugs should be referred to by their generic name rather than by a proprietary name. When a proprietary name must be used, it should begin with a capital letter to indicate this.
References
References should be numbered consecutively in the order that they are first mentioned in the text, and these numbers should be inserted above the line each time the author is cited, eg '...As others have done.2-5,7 The full list of references at the end of the article should be arranged in numerical order. Each reference should include the names and initials of all authors, but if there are more than four the first author may be followed by et al, the title of the article, the unabbreviated title of the journal, the year, the volume, and first and last page numbers. Titles of books should be followed by the place of publication, the publisher, and the year. References to 'unpublished observations' or 'personal communications' should be mentioned in the text but not included in the list of references. The titles of periodicals should be unabbreviated. The style is as follows:
Alcock G, Brown DW. The Minnesota coding of EEGs applied to the evaluation of beta-blockers in ischaemic heart disease. British Medical Journal 1983; 287: 3010-3015.
Alcock G, Brown DW. The Minnesota Coding of EEGs. Macmillan Press: London, 1983
Illustrations
All illustrations (photographs or line drawings) should be about 1.5 times the intended final size. The proportions of the printed page should be borne in mind when authors are preparing the format of illustrations. Glossy prints of photographs are necessary. Any lettering or annotation on photographs or line drawings should be indicated on a tracing overlay or a photocopy of the original. The use of symbols should be consistent. All illustrations should be identified on the back by the name of the principal author and the figure number. If the orientation of an illustration is not obvious it should be indicated on the back. All illustrations should be numbered as figures whether they are photographs, representational drawings or graphs, i.e. Figure 1, Figure 2, Figure 3. Captions for illustrations should be collected together and presented on a separate page. All illustrations should be specifically referred to in the text. Authors will be expected to defray the extra cost of printing any illustrations in colour, estimated at $1000 for the first page and $500 for each additional page. Electronic submission of figures is encouraged. The preferred formats include .EPS and .TIF. Preferred programs include Photoshop, Illustrator and CorelDraw.
Tables
Tables ideally should not have more than 80, and certainly not more than 100, characters to the line (counting spaces between columns as 4 characters) unless absolutely unavoidable. Each table should be on a separate page with its caption. All tables should be specifically referred to in the text.
Proofs
The designated author will receive a pdf proof sent directly to their email address, which should be corrected and returned promptly to the Publisher using the address label provided. Authors will be asked to defray the expense of any alteration after proofing which represents a major departure from the original copy.
E-prints
Access to 25 free e-prints will be provided; the corresponding
author will receive one complimentary copy of the journal for each
contributor.
SAGE Open
If you wish your article to be freely available online immediately upon publication (as some funding bodies now require), you can opt for it to be included in SAGE Open upon payment of a publication fee. Manuscript submission and refereeing procedure is unchanged, but on acceptance of your article you will be asked to let SAGE know directly if you are choosing SAGE Open. For further information please visit http:/www.sagepub.co.uk/sageopen.sp
If funding has been provided for your research, convention dictates that you acknowledge the source and grant information in the Acknowledgements section of your article. Please note that in some cases, grant funders require authors to attribute the funding source, describe the role of the study funding body and include the relevant grant reference numbers.
Business correspondence and enquiries relating to advertising, subscriptions, back issues or reprints should be addressed to:
SAGE Ltd.
1 Oliver's Yard, 55 City Road
London, EC1Y 1SP, UK
Tel: +44 (0)20 7324 8500
Fax: +44 (0)20 7324 8600
Email: info@sagepub.co.uk
English Language Editing Services: Please click here for information on professional English language editing services recommended by SAGE.
Editorial Board
Editorial Board: Susan M. Barlow Independent Consultant, UK
Nursen Basaran Haceteppe University, Turkey
Barbara D. Beck Gradient Corporation, Cambridge, USA
Bas J. Blaauboer University of Utrecht, Netherlands
A R Boobis Imperial College London, UK
G.F Borm Medical Institute for Environmental Hygiene, Germany
Edward J. Calabrese University of Massachusetts, USA
Daniel A. Casciano Director, NCTR, USA
J K Chipman University of Birmingham, UK
Emanuela Corsini University of Milan, Italy
Edmond E. Creppy Univ of Bordeaux II, France
F.A. De Wolff Leiden University, Netherlands
Michael L. Dourson Toxicology Excellence for Risk Assessment, USA
Erik Dybing National Institute of Public Health, Norway
S.J.S. Flora Defence Research & Development Establishment, India
Sidney Green Howard University, USA
Helmut Greim Technical University of Munich, Germany
Mary Gulumian NIOH, South Africa
E.S. Harpur Sanofi-Aventis, UK
Philip Harvey Covance Laboratories, UK
Kenneth Hartigan-Go University of the Philippines, Philippines
Salmann H. Inayat-Hussain Kebangsaan University Malaysia, Malaysia
Thomas A. Lewandowski Gradient Corporation, USA
Timothy C. Marrs Food Standards Agency, UK
Professor John O'Brien Danone Vitapole, France
B. Kevin Park University of Liverpool, UK
Camilla Pease SEAC, Unilever Colworth, UK
Chada S. Reddy University of Missouri-Columbia, USA
Ivonne M.C.M. Rietjens Wageningen University, Netherlands
Tetsuo Satoh Chiba University, Japan
B. Schilter Nestle Research Center, Switzerland
Roel Schins Heinrich-Heine-University Dusseldorf, Germany
Bryan K. Shipp Corporate EH&S, Pfizer Inc, USA
G.B. Van De Voet Leiden University, Netherlands
Willaim J. Waddell University of Louisville, USA
Secretary: Leila Ahlstrom Finnish Institute of Occupational Health, Finland
|
